- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05225454
The Life Style Patterns and the Development Trend of Chronic Diseases in Healthy and Sub-healthy Groups Were Analyzed by Using Data-mining Techniques
May 9, 2022 updated by: Far Eastern Memorial Hospital
Used multi-year health examination member profile by multi-algorithms technology, to find comprehensive key hazard factors or important high-risk group components for metabolic syndrome and chronic kidney disease or more common chronic diseases.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
The proportion of the population over the age of 65 in Taiwan reached 7.10% in 1993.
After Taiwan became an 「aging country」, the originally slow growth of the elderly population (9.9% in 2006) started to increase, and it reached 14.05% in 2018, which was almost 2 times that in 1993.
In addition, Taiwan formally became an 「aged country」as defined globally.
According to the statistical data from the Ministry of the Interior and the data from the National Development Council, it is estimated that the population over the age of 65 is rapidly growing.
It is expected that 6 years later (by 2026), the elderly population in Taiwan will exceed 20%.
Taiwan will formally become the「super-aged country」as defined globally, with a population structure similar to that in Japan, South Korea, Singapore, and some European countries (Department of Statistics, 2018; National Development Council, 2019).
In order to effectively prevent and treat chronic diseases of sub-health populations and develop health management prediction systems that have unlimited market opportunities and potentials, the author intends to extend the achievements of individual projects sponsored by the Ministry of Science and Technology in recent years.
By multi-year complete health examination member profile, this project used multiple algorithms, such as Logistic regression (LR); Classification And Regression Trees (CART); Hierarchical Linear Modeling (HLM); Random forests (RF); Support-Vector Machines (SVM); eXtreme Gradient Boosting (xGBoost); Light Gradient Boosting Machine (LightGBM) and multiple analysis tools to explore the common potential health hazard variables of the sub-health population to establish a comprehensive assessment health management system that can detect chronic diseases early, the research results will be provided for reference in related fields.
Study Type
Observational
Enrollment (Anticipated)
81108
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pan-Chiao Dist.
-
New Taipei City, Pan-Chiao Dist., Taiwan, 22061
- Oriental Institute of Technology / Far Eastern Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
In 2006-2017 of the MJ Health Research Foundation's member, of the de-linked and de-identified annual health check database, about 71,108 people; 2015-2020, the Health2Sync provides [Intelligent Anti-Glucose System], the biometric and behavioral item de-linked and de-identified data, about 10,000 people.
Description
Inclusion Criteria:
- Continuously health screening twice or more in MJ health reports.
- Chronic kidney disease
- Metabolic syndrome
- Or more, common chronic diseases
Exclusion Criteria:
- Participants who have received clinical treatment
- Subjects of other related research diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with metabolic syndrome in kidney disease-related adverse events as assessed by estimated glomerular filtration rate
Time Frame: 2 year
|
Physiological information of participants with chronic kidney disease related adverse events as assessed in metabolic syndrome, by natural longitudinal change from baseline in estimated glomerular filtration rate at 2 years recent in health screening in participants.
|
2 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 3, 2021
Primary Completion (ANTICIPATED)
July 3, 2024
Study Completion (ANTICIPATED)
July 31, 2024
Study Registration Dates
First Submitted
October 21, 2021
First Submitted That Met QC Criteria
January 26, 2022
First Posted (ACTUAL)
February 4, 2022
Study Record Updates
Last Update Posted (ACTUAL)
May 10, 2022
Last Update Submitted That Met QC Criteria
May 9, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 110027-E
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Universidad de los Andes, ChileCompleted
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
-
Mayo ClinicCompleted
-
Taipei Medical University WanFang HospitalUnknownMetabolic Cardiovascular SyndromeTaiwan
-
The Catholic University of KoreaCompletedMetabolic Syndrome X | Metabolic Cardiovascular Syndrome | Insulin Resistance Syndrome X | Dysmetabolic Syndrome XKorea, Republic of
-
Charite University, Berlin, GermanyRecruitingMetabolic Syndrome, Protection AgainstGermany
-
Wageningen University and ResearchPhilips Healthcare; TNO; Friesland Campina; Albert Heijn; Menzis; Smart with food; Vi... and other collaboratorsCompletedMetabolic Syndrome, Protection AgainstNetherlands
-
University of HohenheimGerman Federal Ministry of Education and ResearchCompleted
-
Cairo UniversityCompletedMetabolic Syndrome in WomenEgypt
-
Andalas UniversityHasanuddin University; Universitas Sumatera UtaraCompletedMetabolic Syndrome, Protection AgainstIndonesia